Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 64,260 | 64,027 | 49,614 | 40,375 | 47,226 |
| Operating Income | -64,260 | -64,027 | -49,614 | -40,375 | -47,226 |
| Other Income | 3,837 | 1,187 | 1,947 | 354 | 43 |
| Pre-tax Income | -60,423 | -62,840 | -47,667 | -40,021 | -47,183 |
| Income Tax | -991 | 387 | 261 | 352 | -12 |
| Net Income Continuous | -59,432 | -63,227 | -47,928 | -40,373 | -47,171 |
| Net Income | $-59,432 | $-63,227 | $-47,928 | $-40,373 | $-47,171 |
| EPS Basic Total Ops | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 |
| EPS Basic Continuous Ops | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 |
| EPS Diluted Total Ops | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 |
| EPS Diluted Continuous Ops | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 |
| EBITDA(a) | $-64,206 | $-63,978 | $-49,568 | $-40,331 | $-47,226 |